EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Magnesium Structure‐Function Integration Platform for Spatiotemporal Multi‐Modality Therapy: Combining Hormonotherapy and Immunotherapy in Prostate Cancer

Rui Zan, Qianping Mao, Keyi Wang, Guodong Zou, Shi Yang, Hua Qiu, Xiang Fang, Guiqing Wang, Xinyi Zhou, Jiexia Wen, Shuai Jiang, Ran Huang und 2 weitere

Advanced Science · 2026-02 · 13 (12)

DOI: 10.1002/advs.202515235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.12.2025. Verfasst von Rui Zan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biliary Surgery, Zhongshan Hospital & College of Biomedical Engineering & Yiwu Research Institute, Fudan University, Shanghai, 200032, …. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Hormone Replacement Therapy, Immunotherapy, Magnesium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Science and Technology Committee Rising-Star Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal‐based immunotherapy represents a promising strategy for enhancing antitumor efficacy; however, its clinical application is limited by challenges such as inefficient drug delivery, low specificity, and suboptimal therapeutic outcomes. In this study, a therapeutic platform is constructed on a magnesium (Mg) surface utilizing self‐healing thiolated hyaluronic acid (HA‐SH) and cell membrane‐derived vesicle (CMV) drug system, which improves structural stability, enables spatiotemporal drug release, and facilitates immune‐hormone combination therapy for prostate cancer. CMV with phospholipid bilayers promotes HA‐SH disulfide bond interactions through weak hydrophobic interactions, mitigating corrosion and ensuring structural integrity. Additionally, HA‐SH exhibits glutathione (GSH)‐responsive drug release within the tumor microenvironment. CMV facilitates pH‐sensitive drug delivery and enables efficient cytoplasmic entry via membrane fusion mechanisms, ensuring precise spatiotemporal control. Through drug library screening, ginsenoside Rb1 is identified as a key therapeutic agent, competitively inhibiting androgen receptor signaling. Coupled with hydrogen release from Mg, it induces immunogenic cell death and promotes the formation of tertiary lymphoid structures (TLS) via inhibiting the PI3K‐AKT pathway, achieving synergistic androgen deprivation therapy and immune activation. This implantable drug delivery system effectively tackles mechanical stability, local drug delivery, and systemic immune activation concerns, demonstrating substantial translational promise for various malignancies to improve treatment effectiveness and reduce structural failure risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsHormone Replacement TherapyImmunotherapyMagnesiumMice, Inbred C57BLAnimalsMiceMaleCombined Modality TherapyDrug Delivery SystemsCell Line, TumorTumor MicroenvironmentMice, Inbred BALB C

Stichwörter der Autor:innen

androgen deprivation therapyimmunogenic cell deathmulti‐modality therapyspatiotemporal responsestructure‐function integration

Substanzen

Magnesium

Autor:innen und Institutionen

  • Department of Biliary Surgery, Zhongshan Hospital & College of Biomedical Engineering & Yiwu Research Institute, Fudan University, Shanghai, 200032, P. R. China.
  • Yiwu Research Institute of Fudan University, Yiwu, 322000, P. R. China.
  • State Key Laboratory of Metastable Materials Science and Technology, Yanshan University, Qinhuangdao, 066004, P. R. China.
  • College & Hospital of Stomatology, Key Laboratory of Oral Diseases Research of Anhui Province, Anhui Medical University, Hefei, 230032, P. R. China.
  • School of Mechanical and Automotive Engineering, Shanghai University of Engineering Science, Shanghai, 201620, P. R. China.

ORCID-Profile: Tao Suo

Förderung

  • Shanghai Science and Technology Committee Rising-Star Program

Zitieren

APA

Zan, R., Mao, Q., Wang, K., Zou, G., Yang, S., Qiu, H., Fang, X., Wang, G., Zhou, X., Wen, J., Jiang, S., Huang, R., Peng, Q., & Suo, T. (2026). Magnesium Structure‐Function Integration Platform for Spatiotemporal Multi‐Modality Therapy: Combining Hormonotherapy and Immunotherapy in Prostate Cancer. Advanced Science, 13(12). https://doi.org/10.1002/advs.202515235

Vancouver

Zan R, Mao Q, Wang K, Zou G, Yang S, Qiu H, et al. Magnesium Structure‐Function Integration Platform for Spatiotemporal Multi‐Modality Therapy: Combining Hormonotherapy and Immunotherapy in Prostate Cancer. Advanced Science. 2026;13(12). doi:10.1002/advs.202515235

BibTeX
@article{Zan2026,
  author = {Zan, Rui and Mao, Qianping and Wang, Keyi and Zou, Guodong and Yang, Shi and Qiu, Hua and Fang, Xiang and Wang, Guiqing and Zhou, Xinyi and Wen, Jiexia and Jiang, Shuai and Huang, Ran and Peng, Qiuming and Suo, Tao},
  title = {Magnesium Structure‐Function Integration Platform for Spatiotemporal Multi‐Modality Therapy: Combining Hormonotherapy and Immunotherapy in Prostate Cancer},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {12},
  doi = {10.1002/advs.202515235}
}
Kostenlos starten →